UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040449
Receipt number R000046163
Scientific Title Impact of continued use of antithrombotic drugs on the risk of delayed post-polypectomy bleeding after endoscopic mucosal resection/endoscopic submucosal dissection for gastrointestinal lesions; prospective study
Date of disclosure of the study information 2020/05/19
Last modified on 2021/11/27 10:51:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of continued use of antithrombotic drugs on the risk of delayed post-polypectomy bleeding after endoscopic mucosal resection/endoscopic submucosal dissection for gastrointestinal lesions; prospective study

Acronym

Impact of antithrombotic drugs on the risk of delayed post-polypectomy bleeding after endoscopic mucosal resection/endoscopic submucosal dissection

Scientific Title

Impact of continued use of antithrombotic drugs on the risk of delayed post-polypectomy bleeding after endoscopic mucosal resection/endoscopic submucosal dissection for gastrointestinal lesions; prospective study

Scientific Title:Acronym

Impact of antithrombotic drugs on the risk of delayed post-polypectomy bleeding after endoscopic mucosal resection/endoscopic submucosal dissection

Region

Japan


Condition

Condition

Gastrointestinal lesions treated with endoscopic mucosal resection (including cold snare polypectomy)/ endoscopic submucosal dissection

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We assessed the impact of continued use of antithrombotic drugs on the risk of delayed post-polypectomy bleeding after endoscopic mucosal resection/endoscopic submucosal dissection for gastrointestinal lesions in order to evaluate the necessity of drug withdrawal during the peri-endoscopic period.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Rate of delayed post-polypectomy bleeding related to endoscopic procedure

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Endoscopic mucosal resection (including cold snare polypectomy)/endoscopic submucosal dissection with continued use of antithrombotic drugs

Interventions/Control_2

Endoscopic mucosal resection (including cold snare polypectomy)/endoscopic submucosal dissection with temporary cessation of antithrombotic drugs

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Patients with gastrointestinal lesions treated with endoscopic mucosal resection (including cold snare polypectomy)/endoscopic submucosal dissection.
2. Patients taking antithrombotic drugs.
3. Patients explained about the study protocol with comprehension, and agreed to participate with written informed consent.

Key exclusion criteria

1. Patients having another severe disorder.
2. Patients with hemostatic disorder.
3. Patients who are judged by the investigators to be inappropriate participants in the study.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Manabu
Middle name
Last name Takeuchi

Organization

Nagaoka Red Cross Hospital

Division name

Division of Gastroenterology and Hepatology

Zip code

940-2085

Address

2-297-1, Senshu, Nagaoka, Niigata, 940-2085, Japan

TEL

0258-28-3600

Email

yasuzuka2000@yahoo.co.jp


Public contact

Name of contact person

1st name Takamasa
Middle name
Last name Kobayashi

Organization

Nagaoka Red Cross Hospital

Division name

Division of Gastroenterology and Hepatology

Zip code

940-2085

Address

2-297-1, Senshu, Nagaoka, Niigata, 940-2085, Japan

TEL

0258-28-3600

Homepage URL


Email

tkmsjpn@gmail.com


Sponsor or person

Institute

Nagaoka Red Cross Hospital

Institute

Department

Personal name



Funding Source

Organization

N/A

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagaoka Red Cross Hospital

Address

2-297-1, Senshu, Nagaoka, Niigata, 940-2085, Japan

Tel

0258-28-3600

Email

shomu@nagaoka.jrc.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 05 Month 19 Day


Related information

URL releasing protocol

https://jgo.amegroups.com/article/view/54206/html

Publication of results

Published


Result

URL related to results and publications

https://jgo.amegroups.com/article/view/54206/html

Number of participants that the trial has enrolled

283

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 10 Month 18 Day

Date of IRB

2019 Year 10 Month 16 Day

Anticipated trial start date

2019 Year 10 Month 18 Day

Last follow-up date

2021 Year 10 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 05 Month 19 Day

Last modified on

2021 Year 11 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046163


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name